Page 56 - MemoriaSAM-Eng

SCIENTIFIC ACTIVITY

Web dissemination of CIBERSAM group publications:

•
Article: Behavioral, neurochemical and morphological changes induced by the overexpres-

sion of munc18-1a in brain of mice: relevance to schizophrenia, published in Translational
Psychiatry journal. The authors are members of CIBERSAM groups G07, G09, G12, G16,

G18 and G20.
•
Article: Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis:
Toward an Integrative Inflammatory Hypothesis of Schizophrenia, published in Schizophre-

nia Bulletin. The authors are members of CIBERSAM groups G01, G04, G05, G10, G12, G13,
G18 and G19.

• Article: Diversity in human conduct: genes, environment or both?, published in Biological

online. The authors are members of group G08
•
Article: Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS
disorders, published in the Nature Reviews Neuroscience journal. The authors are members

of CIBERSAM group G24.

• Article: Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized
Controlled Study, published in the American Journal of Psychiatry. The authors are members

of CIBERSAM groups G01, G03, G05, G10, G15, G17, G21, G22, G24, G25.

• Article: Brain Effects of Cognitive Remediation Therapy in Schizophrenia: A Structural and
Functional Neuroimaging Study published in the Biological Psychiatry journal. The authors
í
are members of CIBERSAM group G04.

• Article: Should obesity be considered a limiting factor in treatment with clozapine? Pu-
blished in the Psiquiatyría y Salud Mental journal. The authors are members of CIBERSAM

group G04.

• Article: Early Responses to Deep Brain Stimulation in Depression are Modulated by Anti-in-
flammatory Drugs, published in the Molecular Psychiatry journal. The authors are members

of CIBERSAM groups G18, G19, G12 and G21.

• Article: Peripheral endocannabinoid system dysregulation in first-episode psychosis, pu-
blished in the Neuropsychopharmacology journal. The authors are members of CIBERSAM

groups G01, G04, G05, G10, G12, G13 and G19.

• Article: A double-blind placebo-controlled study of efficacy of reboxetine and citalopram as
adjuvant of atypical antipsychotics in negative symptoms of schizophrenia, published in the

Journal of Clinical Psychiatry. The authors are members of CIBERSAM group G11.

•
Book: Abordaje Integral de las Fases Iniciales de la psicosis. Una Visión Crítica (Compre-
hensive Approach to Initial Stages of Psychosis. A Critical Vision), published by Editorial

Panamericana. The authors are members of CIBERSAM group G16.

Patent communication:

• Dissemination in the mass media (La Vanguardia, ABC, Diario Médico...) of the
é
patent entitled: “Method for predicting the start of extrapyramidal symptoms induced
by antipsychotic-based treatment” involving the participation of CIBERSAM, the 13
ó0
Universidad Clnic, the Instituto de Investigaciones Biomdicas August Pi i Sunyer 2
(IDIBAPS) and the Universidad de Barcelona with the Fundacin Bosch i Gimpera of RT
O
Universidad de Barcelona.
EP
R
AL
Dissemination of European and national calls for proposal through the CIBER- U
NN
SAM web page:
A
/
• ROAMER project meetings (FP7/2007-2013/no. 282586) M
SA
• Calls for proposals for the 2020 Horizon Programme.
R
BE
CI
CIBERSAM Dissemination in social networks:
56
• Creation and dissemination of CIBERSAM’s twitter account (@ciber_sam).